Project 1 - Central thymic tolerance as a major checkpoint in T1D
Project 1 - Central thymic tolerance as a major checkpoint in T1D
批准号:
9151388
负责人:
Mark S Anderson
金额:
$39.63万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-08 至 2021-05-31
关键词:
AblationAddressAffectAffinityAllelesAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityCell Differentiation processCell SurvivalCellsCloningCollaborationsComplexDataDefectDevelopmentDiabetes MellitusDiseaseDisease modelGenerationsGenesGenetic PolymorphismHumanImmune ToleranceInbred NOD MiceIncidenceIndividualInsulinInsulin-Dependent Diabetes MellitusLinkMinisatellite RepeatsModelingMusMutationNon obesePathogenesisPatientsPeptide LibraryPeptide/MHC ComplexPeptidesPeripheralPlayProcessReagentRegulator GenesRegulatory T-LymphocyteReporterRiskRoleShapesSiteSorting - Cell MovementSpecificitySusceptibility GeneSyndromeSystemT cell responseT-LymphocyteTechniquesTestingThymic epithelial cellThymus GlandTransgenic Organismsabstractingcentral tolerancedeep sequencingdiabeticimprovedisletmouse modelthymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
As the site of both negative selection of developing thymocytes and generation of regulatory T cells (Tregs),
the thymus plays a critical role in the multi-layered network of immune tolerance. The fate of a developing T
cell is dependent on the affinity of the interaction between the TCR and the peptide-MHC complex it
recognizes, with the highest affinity interactions resulting in deletion or Treg induction and lower affinity
interactions resulting in T cell survival and differentiation. The Autoimmune Regulator (Aire) is a major
transcriptional regulator of peripheral self-antigen expression within the thymus, and loss of Aire leads to
defects in negative selection due to reduced or absent thymic antigen expression in specialized medullary
thymic epithelial cells (mTECs). Several lines of evidence point to this process as playing an important role in
the pathogenesis of type 1 diabetes. Here, we will use type 1 diabetes as a model disease system to further
unravel how insulin-specific T cells arise from the thymus that are both T effectors and T regulatory cells.
Our specific aims are:
AIM1: Define the role of Aire and thymic insulin expression on the thymic deletion of insB(9-23) specific T cells.
AIM2: Define the repertoire and specificity of thymic Foxp3+ T regulatory cells selected by Aire-expressing
cells.
These studies will be performed in close collaboration with PPG projects 2 (Bluestone) and 3 (Kappler) and
will help improve our understanding of how the T cell repertoire is shaped in the thymus in the setting of type 1
diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10328098
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10576386
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10328097
-
项目类别:
-
资助金额:$176.58万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10630946
-
项目类别:
-
资助金额:$46.85万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10502136
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Project 2: STAT3 as a trigger for T1D
-
批准号:10328102
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10328099
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
-
批准号:10503923
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
-
批准号:10683384
-
项目类别:
-
资助金额:$66.63万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Core A: Mouse Core
-
批准号:10576378
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
STAT3 variants as a rheostat of immune tolerance
-
批准号:10576375
-
项目类别:
-
资助金额:$176.56万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Administrative Core
-
批准号:10576377
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2022
-
负责人:Mark S Anderson
-
依托单位:
Immune Tolerance Network
-
批准号:10625931
-
项目类别:
-
资助金额:$684.91万
-
财政年份:2021
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10179371
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10413178
-
项目类别:
-
资助金额:$95.17万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10020398
-
项目类别:
-
资助金额:$95.13万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
-
批准号:10762177
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2019
-
负责人:Mark S Anderson
-
依托单位:
Using human stem cell-derived thymic epithelium to remodel T1D immune tolerance
-
批准号:9106605
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Core A - Animal core
-
批准号:9151386
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
Disruption of T cell tolerance in type 1 diabetes
-
批准号:9291418
-
项目类别:
-
资助金额:$162.91万
-
财政年份:2016
-
负责人:Mark S Anderson
-
依托单位:
海外基金